HCV selection and HVR1 evolution in a chimpanzee chronically infected with HCV-1 over 12 years

Hepatology Research

Volumn 38, Issue 7, 2008, Pages 704-716

  Lu, Ling ^a   Tatsunori, Nakano ^b   Li, Chunhua ^a   Waheed, Sana ^a   Gao, Fengxiang ^c   Robertson, Betty H ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Public Health Laboratories

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Ichinomiya Nishi Hospital   (Japan)

Author keywords

Chimpanzee; HCV; HVR1; Quasi species; Sequencing

Indexed keywords

ACUTE HEPATITIS; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHIMPANZEE; CONSENSUS SEQUENCE; CONSERVATION GENETICS; GENE STRUCTURE; GENETIC SELECTION; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS C VIRUS 1; INOCULATION; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION;

EID: 44649155139     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00320.x     Document Type: Article

References (56)

1. Alter M. Transmission of hepatitis C virus - route, dose, and titer. N Engl J Med 1994; 330: 784-6.
2. Choo Q, Kuo G, Weiner A etal. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
3. Alter H, Seeff L. Recovery, persistence, and sequelae in hepatitis C virus infection: A perspective on long-term outcome. Semin Liver Dis 2000; 20: 17-35.
4. Alter M. Epidemiology of hepatitis C. Hepatology 1997; 26: 62S-5S.
5. Lu L, Li C, Fu Y et al. Complete genomic sequences for hepatitis C virus subtypes 6f, 6i, 6j, and 6m isolated from five Thai blood donors and two infected spouses with inference to sexual transmission. J Gen Virol 2007; 88: 1505-18.
6. Farci P, Shimoda A, Coiana A et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 2000; 228: 339-44.
7. Herring B, Tsui R, Peddada L et al. Wide range of quasispecies diversity during primary hepatitis C virus infection. J Virol 2005; 79: 4340-6.
8. Lin H, Seeff L, Barbosa L etal. Occurrence of identical hypervariable region 1 sequences of hepatitis C virus in transfusion recipients and their respective blood donors: Divergence over time. Hepatology 2001; 34: 424-9.
9. Manzin A, Solforosi L, Petrelli E etal. Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J Virol 1998; 72: 6271-6.
10. Takeda T, Tatsumi N, Nakayama Y etal. Mode of HCV infection examined by polymorphism of hypervariable region-1 in cases of acute hepatitis C after accidental exposure to blood-borne pathogens. J Med Virol 2005; 75: 35-41.
11. Gomez J, Martell M, Quer J etal. Hepatitis C viral quasispecies. J Viral Hepat 1999; 6: 3-16.
12. Pawlotsky J. Hepatitis C virus infection: Virus/host interactions. J Viral Hepat 1998; 5 (Suppl 1): 3-8.
13. Hijikata M, Kato N, Ootsuyama Y et al. Hypervariable regions in the putative glycoprotein of hepatitis C virus. Biochem Biophys Res Commun 1991; 175: 220-8.
14. Weiner A, Brauer M, Rosenblatt J et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180: 842-8.
15. Bukh J, Miller R, Purcell R. Genetic heterogeneity of hepatitis C virus: quasispecies and genotype. Semin Liver Dis 1995; 15: 41-63.
16. Farci P, Bukh J, Purcell R. The quasispecies of hepatitis C virus and the host immune response. Springer Semin Immunopathol 1997; 19: 5-26.
17. Forns X, Purcell R, Bukh J. Quasispecies in viral persistence and pathogenesis of hepatitis C virus. Trends Microbiol 1999; 7: 402-10.
18. Smith D. Evolution of the hypervariable region of hepatitis C virus. J Viral Hepat 1999; 6 (Suppl 1): 41-6.
19. Shirai M, Arichi T, Nishioka M etal. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1. J Immunol 1995; 154: 2733-42.
20. Kato N, Sekiya H, Ootsuyama Y etal. Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp70) of hepatitis C virus. J Virol 1993; 67: 3923-30.
21. Weiner A, Geysen H, Christopherson C etal. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci USA 1992; 89: 3468-72.
22. Farci P, Alter H, Wong D etal. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994; 91: 7792-6.
23. Farci P, Shimoda A, Wong D etal. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 1996; 93: 15394-9.
24. Shimizu Y, Igarashi H, Kiyohara T et al. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 1996; 223: 409-12.
25. Shimizu Y, Hijikata M, Iwamoto A etal. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol 1994; 68: 1494-500.
26. Higashi Y, Kakumu S, Yoshioka K et al. Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 1993; 197: 659-68.
27. Ray S, Wang Y, Laeyendecker O etal. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy. J Virol 1999; 73: 2938-46.
28. van Doorn L, Capriles I, Maertens G etal. Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. J Virol 1995; 69: 773-8.
29. Casino C, McAllister J, Davidson F etal. Variation of hepatitis C virus following serial transmission: Multiple mechanisms of diversification of the hypervariable region and evidence for convergent genome evolution. J Gen Virol 1999; 80: 717-25.
30. Gao G, Buskell Z, Seeff L etal. Drift in the hypervariable region of the hepatitis C virus during 27 years in two patients. J Med Virol 2002; 68: 60-7.
31. McAllister J, Casino C, Davidson F etal. Long-term evolution of the hypervariable region of hepatitis C virus in a common-source-infected cohort. J Virol 1998; 72: 4893-905.
32. Bassett S, Brasky K, Lanford R. Analysis of hepatitis C virus-inoculated chimpanzees reveals unexpected clinical profiles. J Virol 1998; 72: 2589-99.
33. Bassett S, Thomas D, Brasky K etal. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees. J Virol 1999; 73: 1118-26.
34. Ray S, Mao Q, Lanford R etal. Hypervariable region 1 sequence stability during hepatitis C virus replication in chimpanzees. J Virol 2000; 74: 3058-66.
35. Kolykhalov A, Agapov E, Blight K etal. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 1997; 277: 570-4.
36. Major M, Mihalik K, Fernandez J etal. Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol 1999; 73: 3317-25.
37. Bradley D, Krawczynski K, Ebert J et al. Parenterally transmitted non-A, non-B hepatitis: Virus-specific antibody response patterns in hepatitis C virus-infected chimpanzees. Gastroenterology 1990; 99: 1054-60.
38. Nainan O, Lu L, Gao F et al. Selective transmission of hepatitis C virus genotypes and quasispecies in humans and experimentally infected chimpanzees. J Gen Virol 2006; 87: 83-91.
39. Bradley D, Cook E, Maynard J et al. Experimental infection of chimpanzees with antihemophilic (factor VIII) materials: Recovery of virus-like particles associated with non-A, non-B hepatitis. J Med Virol 1979; 3: 253-69.
40. Lu L, Nakano T, Orito E etal. Evaluation of accumulation of hepatitis C virus mutations in a chronically infected chimpanzee: Comparison of the core, E1, HVR1, and NS5b regions. J Virol 2001; 75: 3004-9.
41. Martell M, Gomez J, Esteban J etal. High-throughput real-time reverse transcription-PCR quantitation of hepatitis C virus RNA. J Clin Microbiol 1999; 37: 327-32.
42. Gojobori T, Moriyama E, Kimura M. Molecular clock of viral evolution, and the neutral theory. Proc Natl Acad Sci USA 1990; 87: 10015-18.
43. Preston F, Jarvis L, Makris M etal. Heterogeneity of hepatitis C virus genotypes in hemophilia: Relationship with chronic liver disease. Blood 1995; 85: 1259-62.
44. Franchini M, Capra F, Tagliaferri A et al. Update on chronic hepatitis C in hemophiliacs. Haematologica 2002; 87: 542-9.
45. Dieterich D. Hepatitis C virus and human immunodeficiency virus: clinical issues in coinfection. Am J Med 1999; 107: 79S-84S.
46. Sabin C, Telfer P, Phillips A et al. The association between hepatitis C virus genotype and human immunodeficiency virus disease progression in a cohort of hemophilic men. J Infect Dis 1997; 175: 164-8.
47. Gordon S, Elloway R, Long J etal. The pathology of hepatitis C as a function of mode of transmission: Blood transfusion vs. intravenous drug use. Hepatology 1993; 18: 1338-43.
48. Okamoto H, Mishiro S, Tokita H etal. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/ 2a or I/1a. Hepatology 1994; 20: 1131-6.
49. Fan X, Lang D, Xu Y etal. Liver transplantation with hepatitis C virus-infected graft: Interaction between donor and recipient viral strains. Hepatology 2003; 38: 25-33.
50. Radkowski M, Wilkinson J, Nowicki M etal. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: Evidence of replication. J Virol 2002; 76: 600-8.
51. Roy K, Bagg J, McCarron B et al. Predominance of HCV type 2a in saliva from intravenous drug users. J Med Virol 1998; 54: 271-5.
52. Roque-Afonso A, Ducoulombier D, Di Liberto G et al. Compartmentalization of hepatitis C virus genotypes between plasma and peripheral blood mononuclear cells. J Virol 2005; 79: 6349-57.
53. Wyatt C, Andrus L, Brotman B et al. Immunity in chimpanzees chronically infected with hepatitis C virus: Role of minor quasispecies in reinfection. J Virol 1998; 72: 1725-30.
54. Kao J, Chen P, Lai M et al. Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis. Gastroenterology 1993; 105: 583-7.
55. Di Liberto G, Roque-Afonso A, Kara R etal. Clinical and therapeutic implications of hepatitis C virus compartmentalization. Gastroenterology 2006; 131: 76-84.
56. Ray S, Fanning L, Wang X etal. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 2005; 201: 1753-9.